Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions

Author:

Engel Gonzalez Pedro1ORCID,Gregerson Samuel2,Mahmood Shazil2,Brooks Collin3,Villablanca Pedro A.1,Frisoli Tiberio M.1,Lee James1,Wyman Janet F.1,Wang Dee Dee1ORCID,O'Neill William W.1,O'Neill Brian P.1ORCID

Affiliation:

1. Center for Structural Heart Disease, Division of Cardiology Henry Ford Hospital Detroit Michigan USA

2. Department of Internal Medicine Henry Ford Hospital Detroit Michigan USA

3. Wayne State University School of Medicine Detroit Michigan USA

Abstract

AbstractBackgroundThe clinical efficacy and safety of alcohol septal ablation (ASA) for obstructive hypertrophic cardiomyopathy (HCM) have been well‐established; however, less is known about outcomes in patients undergoing preemptive ASA before transcatheter mitral valve replacement (TMVR).AimsThe goal of this study is to characterize the procedural characteristics and examine the clinical outcomes of ASA in both HCM and pre‐TMVR.MethodsThis retrospective study compared procedural characteristics and outcomes in patient who underwent ASA for HCM and TMVR.ResultsIn total, 137 patients were included, 86 in the HCM group and 51 in the TMVR group. The intraventricular septal thickness (mean 1.8 vs. 1.2 cm; p < 0.0001) and the pre‐ASA LVOT gradient (73.6 vs. 33.8 mmHg; p ≤ 0.001) were higher in the HCM group vs the TMVR group. The mean volume of ethanol injected was higher (mean 2.4 vs. 1.7 cc; p < 0.0001). The average neo‐left ventricular outflow tract area increased significantly after ASA in the patients undergoing TMVR (99.2 ± 83.37 mm2 vs. 196.5 ± 114.55 mm2; p = <0.0001). The HCM group had a greater reduction in the LVOT gradient after ASA vs the TMVR group (49.3 vs. 18 mmHg; p = 0.0040). The primary composite endpoint was higher in the TMVR group versus the HCM group (50.9% vs. 25.6%; p = 0.0404) and had a higher incidence of new permanent pacemaker (PPM) (25.5% vs. 18.6%; p = 0.3402). The TMVR group had a higher rate of all‐cause mortality (9.8% vs. 1.2%; p = 0.0268).ConclusionsPreemptive ASA before TMVR was performed in patients with higher degree of clinical comorbidities, and correspondingly is associated with worse short‐term clinical outcomes in comparison to ASA for HCM patients. ASA before TMVR enabled percutaneous mitral interventions in a small but significant minority of patients that would have otherwise been excluded. The degree of LVOT and neoLVOT area increase is significant and predictable.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3